Aclarion, Inc. (ACON)Healthcare | Health Information Services | Broomfield, United States | NasdaqCM
2.40 USD
-0.12
(-4.762%) ⇩
(Aug. 28, 2026, 4 p.m.
EDT)
After hours: 2.40 |
Hot Take ↕ | Aug. 22, 2026, 2:10 a.m. EDT
The immediate outlook is bearish as the stock trades significantly below its 50-day moving average, reflecting recent weakness where support levels have been breached. While the company recently secured financing and announced a share repurchase plan to shore up liquidity, these defensive moves come alongside a missed revenue estimate and a trailing twelve-month loss of nearly $7 per share. The valuation metrics are distorted by negative earnings, rendering traditional multiples useless, though the book value suggests the shares trade at a deep discount to assets. However, the long-term picture is severely compromised by a catastrophic multi-year decline; the price has erased virtually all gains over the last three years, with every single year showing negative returns. This persistent structural deterioration, combined with negative operating cash flow and a lack of analyst coverage, indicates that the market has lost faith in the business's ability to sustain growth or profitability. There is no dividend to provide income, and the combination of deteriorating fundamentals and a relentless downward price trajectory makes this a high-risk speculative vehicle rather than an investment. |
| Model | MAE |
|---|---|
| AutoTheta ✓ | 0.177396 |
| MSTL | 0.192567 |
| AutoETS | 0.196028 |
| AutoARIMA | 0.197493 |
Forecast horizon: 45 days | Selected: AutoTheta
| Forecast Reliability | |
|---|---|
| Score | 34% |
| H-stat | 21.24 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.402 |
| Excess Kurtosis | -0.38 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Revenue per Share | 0.057 |
| Market Cap | 6,917,690 |
| Forward P/E | -0.44 |
| Beta | 1.22 |
| Previous Name | Coin Gabbar |
| Website | https://www.aclarion.com |
| Attribute | Value |
|---|---|
| 52 Week Change | -0.6475525 |
| Address1 | 8,181 Arista Place |
| Address2 | Suite 100 |
| All Time High | 586,116.0 |
| All Time Low | 1.95 |
| Ask | 3.04 |
| Ask Size | 2 |
| Average Daily Volume10 Day | 89,480 |
| Average Daily Volume3 Month | 63,204 |
| Average Volume | 63,204 |
| Average Volume10Days | 89,480 |
| Beta | 1.216 |
| Bid | 1.78 |
| Bid Size | 2 |
| Book Value | 6.905 |
| City | Broomfield |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 2.4 |
| Current Ratio | 16.196 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,786,665,600 |
| Day High | 2.52 |
| Day Low | 2.355 |
| Display Name | Aclarion |
| Ebitda | -9,468,166 |
| Ebitda Margins | 0.0 |
| Enterprise To Ebitda | 0.99 |
| Enterprise To Revenue | -111.948 |
| Enterprise Value | -9,377,772 |
| Eps Current Year | -4.51 |
| Eps Forward | -5.47 |
| Eps Trailing Twelve Months | -6.96 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 2.61458 |
| Fifty Day Average Change | -0.21457982 |
| Fifty Day Average Change Percent | -0.08207048 |
| Fifty Two Week Change Percent | -64.75525 |
| Fifty Two Week High | 12.03 |
| Fifty Two Week High Change | -9.629999 |
| Fifty Two Week High Change Percent | -0.8004987 |
| Fifty Two Week Low | 1.95 |
| Fifty Two Week Low Change | 0.45000005 |
| Fifty Two Week Low Change Percent | 0.23076925 |
| Fifty Two Week Range | 1.95 - 12.03 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,650,634,200,000 |
| Float Shares | 2,500,428 |
| Forward Eps | -5.47 |
| Forward P E | -0.43875688 |
| Free Cashflow | -5,323,035 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 10 |
| Fullday Change | -0.12 |
| Fullday Change Percent | -4.7619 |
| Fullday Price | 2.4 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.21755 |
| Gross Profits | 18,224 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.23976 |
| Held Percent Institutions | 0.040009998 |
| Implied Shares Outstanding | 2,882,371 |
| Industry | Health Information Services |
| Industry Disp | Health Information Services |
| Industry Key | health-information-services |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Last Split Date | 1,743,120,000 |
| Last Split Factor | 1:27 |
| Long Business Summary | Aclarion, Inc. operates as a healthcare technology company in the United States. It uses magnetic resonance spectroscopy (MRS) combined with proprietary signal-processing biomarkers to optimize clinical treatments. The company develops NOCISCAN, which uses MRS capabilities to non-invasively analyze the chemical makeup of intervertebral discs in the spine. It also provides NOCISCAN MRS Exam Protocol, a custom software protocol for using commercially available MRS pulse sequences in scanning intervertebral discs which extends the time of a standard lumbar MRI exam; and imaging data transfer products, including AMBRA Healthcare, a data transfer platform. In addition, the company offers The NOCISCAN Post-Processor Suite comprising NOCICALC, a Class I medical device that receives the raw un-processed NOCISCAN MRS exam data and post-processes that raw data into final spectra, and performs various degenerative pain biomarker calculations from those spectra, for each disc examined; and NOCIGRAM, which further processes the NOCICALC results into individual NOCISCORES, on a 0-10 scale, that represent the different relative levels of degenerative pain biomarkers the various discs examined in the patient. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc. was incorporated in 2008 and is based in Broomfield, Colorado. |
| Long Name | Aclarion, Inc. |
| Market | us_market |
| Market Cap | 6,917,690 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_108179695 |
| Most Recent Quarter | 1,782,777,600 |
| Name Change Date | 2,026-08-28 |
| Net Income To Common | -9,196,562 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 7,090,632 |
| Number Of Analyst Opinions | 1 |
| Open | 2.52 |
| Operating Cashflow | -8,086,706 |
| Operating Margins | -115.031815 |
| Payout Ratio | 0.0 |
| Phone | 833 275 2266 |
| Post Market Change | 0.0 |
| Post Market Change Percent | 0.0 |
| Post Market Price | 2.4 |
| Post Market Time | 1,787,947,804 |
| Prev Name | Coin Gabbar |
| Previous Close | 2.52 |
| Price Eps Current Year | -0.53215075 |
| Price Hint | 4 |
| Price To Book | 0.34757423 |
| Price To Sales Trailing12 Months | 82.58055 |
| Profit Margins | 0.0 |
| Quick Ratio | 15.742 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | -0.12 |
| Regular Market Change Percent | -4.7619 |
| Regular Market Day High | 2.52 |
| Regular Market Day Low | 2.355 |
| Regular Market Day Range | 2.355 - 2.52 |
| Regular Market Open | 2.52 |
| Regular Market Previous Close | 2.52 |
| Regular Market Price | 2.4 |
| Regular Market Time | 1,787,947,201 |
| Regular Market Volume | 35,254 |
| Return On Assets | -0.37014 |
| Return On Equity | -0.58966 |
| Revenue Growth | 0.305 |
| Revenue Per Share | 0.057 |
| Sand P52 Week Change | 0.20504117 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 2,882,371 |
| Shares Percent Shares Out | 0.0215 |
| Shares Short | 61,992 |
| Shares Short Previous Month Date | 1,784,073,600 |
| Shares Short Prior Month | 42,704 |
| Short Name | Aclarion, Inc. |
| Short Percent Of Float | 0.0215 |
| Short Ratio | 1.31 |
| Source Interval | 15 |
| State | CO |
| Symbol | ACON |
| Target High Price | 7.5 |
| Target Low Price | 7.5 |
| Target Mean Price | 7.5 |
| Target Median Price | 7.5 |
| Total Cash | 16,295,462 |
| Total Cash Per Share | 5.653 |
| Total Debt | 0 |
| Total Revenue | 83,769 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -6.96 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 3.678485 |
| Two Hundred Day Average Change | -1.2784848 |
| Two Hundred Day Average Change Percent | -0.34755746 |
| Type Disp | Equity |
| Volume | 35,254 |
| Website | https://www.aclarion.com |
| Zip | 80,021 |